LGMN and Patent ductus arteriosus: Additionally, DCs treated with PDA tumor cells-derived EVs had varied lncRNA and mRNA expression profiles, with downregulation of genes potentially leading to DC-mediated immune escape such as lgmn, an enzyme involved in the processing of toxins and endogenous proteins for MHC-II presentation [133].